Vaxart, Inc. Files 8-K Report
Ticker: VXRT · Form: 8-K · Filed: Mar 11, 2025 · CIK: 72444
| Field | Detail |
|---|---|
| Company | Vaxart, Inc. (VXRT) |
| Form Type | 8-K |
| Filed Date | Mar 11, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, corporate-filing, historical-information
TL;DR
Vaxart filed an 8-K on 3/11/25, mostly routine stuff and past name changes.
AI Summary
On March 11, 2025, Vaxart, Inc. filed an 8-K report. The filing primarily concerns other events and financial statements/exhibits. Vaxart, Inc. was formerly known as Aviragen Therapeutics, Inc., Biota Pharmaceuticals, Inc., and NABI BIOPHARMACEUTICALS, with name changes occurring in 2016, 2012, and 2010, respectively.
Why It Matters
This 8-K filing indicates routine corporate updates and the submission of financial information, which is standard for publicly traded companies.
Risk Assessment
Risk Level: low — The filing appears to be a routine 8-K for corporate updates and financial disclosures, with no immediate indication of significant new risks.
Key Players & Entities
- Vaxart, Inc. (company) — Registrant
- Aviragen Therapeutics, Inc. (company) — Former Company Name
- Biota Pharmaceuticals, Inc. (company) — Former Company Name
- NABI BIOPHARMACEUTICALS (company) — Former Company Name
- March 11, 2025 (date) — Date of Report
FAQ
What is the primary purpose of this 8-K filing by Vaxart, Inc. on March 11, 2025?
The filing is for 'Other Events' and 'Financial Statements and Exhibits', indicating routine corporate updates and disclosures.
What were Vaxart, Inc.'s previous names and when did these name changes occur?
Vaxart, Inc. was formerly known as Aviragen Therapeutics, Inc. (name change in 2016), Biota Pharmaceuticals, Inc. (name change in 2012), and NABI BIOPHARMACEUTICALS (name change in 2010).
What is Vaxart, Inc.'s state of incorporation and IRS Employer Identification Number?
Vaxart, Inc. is incorporated in Delaware and its IRS Employer Identification Number is 59-1212264.
What is the principal executive office address for Vaxart, Inc.?
The principal executive offices are located at 170 Harbor Way, Suite 300, South San Francisco, California 94080.
What is the SIC code for Vaxart, Inc. and what does it represent?
The SIC code is 2836, which represents 'BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES)'.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 11, 2025 regarding Vaxart, Inc. (VXRT).